Next Article in Journal
LAA Occluders for All Patients with Atrial Fibrillation - An Overreaching Statement
Previous Article in Journal
Loss of Biventricular Pacing: What’s the Problem?
 
 
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Author’s Reply

by
Fabian Nietlispach
* and
Francesco Maisano
University Heart Center Zurich, Zurich, Switzerland
*
Author to whom correspondence should be addressed.
Cardiovasc. Med. 2017, 20(3), 78; https://doi.org/10.4414/cvm.2017.00468
Submission received: 15 December 2016 / Revised: 15 January 2017 / Accepted: 15 February 2017 / Published: 15 March 2017
With pleasure we read the letter to the Editor by Kühne et al. We highly respect the conservative opinion of our colleagues. However, in our daily practice we are confronted with an important question: should we really withhold an established preventive therapy from patients and wait until they experience a complication?
The authors criticise left atrial appendage occlusion (LAAO), but leave the reader without any alternatives. Knowing that nonvitamin-K-antagonist oral anticoagulants (NOACS) have a discontinuation rate of at least 15% (RE-LY [1]) and >15% major and clinically relevant bleedings per year [2], the complication rate of 4.9% for LAAO is at least competitive.
During the years 2012–2015, a total of 273 LAAOs have been performed at the University Hospital Zurich, 428 at the University Hospital Berne and only 25 at the University Hospital Basel. We respect our colleagues who wait until stronger evidence becomes available, but we believe that it is the duty of a university hospital to change daily practice for the better for our patients and to create new evidence. Since we share the same passion for quotes as the authors do, we would like to give Kühne et al. two quotes along the way: the former US president John F. Kennedy said in 1963 “Change is the law of life. And those who look only to the past or the present are certain to miss the future.” And in contrast to the previous quote, Wilhelm II Emperor of Germany (1916) once said “I believe in the horse, the automobile is a temporary appearance.”

References

  1. Connolly, S.J.; Ezekowitz, M.D.; Yusuf, S.; Eikelboom, J.; Oldgren, J.; Parekh, A.; et al.; RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009, 361, 1139–1151. [Google Scholar] [CrossRef] [PubMed]
  2. Patel, M.R.; Mahaffey, K.W.; Garg, J.; Pan, G.; Singer, D.E.; Hacke, W.; et al.; ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365, 883–891. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Nietlispach, F.; Maisano, F. Author’s Reply. Cardiovasc. Med. 2017, 20, 78. https://doi.org/10.4414/cvm.2017.00468

AMA Style

Nietlispach F, Maisano F. Author’s Reply. Cardiovascular Medicine. 2017; 20(3):78. https://doi.org/10.4414/cvm.2017.00468

Chicago/Turabian Style

Nietlispach, Fabian, and Francesco Maisano. 2017. "Author’s Reply" Cardiovascular Medicine 20, no. 3: 78. https://doi.org/10.4414/cvm.2017.00468

APA Style

Nietlispach, F., & Maisano, F. (2017). Author’s Reply. Cardiovascular Medicine, 20(3), 78. https://doi.org/10.4414/cvm.2017.00468

Article Metrics

Back to TopTop